Prohibiting Abortion Industry’s Lucrative Loopholes Act

# Summary of HR 727: Prohibiting Abortion Industry's Lucrative Loopholes Act This bill, introduced by Rep. Scott Franklin (R-FL), would restrict the sale and transfer of fetal tissue and human embryonic cells. The legislation aims to close what sponsors describe as "loopholes" in existing federal law that regulates the handling of fetal tissue from abortions. The bill would place stricter limitations on how fetal tissue can be used, sold, or distributed, and would extend these restrictions to embryonic stem cells and other related biological materials. The bill primarily affects abortion clinics, medical research institutions, and biotech companies that use fetal tissue or embryonic cells in their research.

It would also impact women seeking abortions who may currently have the option to donate fetal tissue for medical research purposes. The legislation builds on existing federal restrictions like the Dickey-Wicker Amendment, which already prohibits federal funding for certain fetal tissue research. **Current Status:** The bill is currently in committee and has not been voted on by the full House. As with most bills introduced in Congress, it faces an uncertain path to passage. The bill reflects ongoing partisan debate over abortion policy and the use of fetal materials in medical research—topics where lawmakers hold sharply different views based on their values and beliefs about when life begins.